Biopharmaceutical Manufacturing Preparedness Consortium (BioMaP-Consortium)

1 on 1 Meetings

1-on-1 Meeting Request for Onshoring VHF Vaccine

As outlined during the Onshoring the Manufacturing of Viral Hemorrhagic Fever Vaccine Candidates Industry Day event on Aug. 28, 2025, 1-on-1 meetings are available for Contract Development and Manufacturing Organizations interested in partnering with the International AIDS Vaccine Initiative (IAVI) and/or Public Health Vaccines (PHV). To request a meeting with IAVI or PHV, please complete the meeting request form linked below.

Form Closes: Sept. 2, 2025 at 12 p.m. ET

Draft SOO Option 2

Draft Statement of Objectives for Monoclonal Antibody Advanced Manufacturing Capability Improvement

The BioMaP-Consortium has released a Draft Statement of Objectives on behalf of BARDA to gather stakeholder feedback. Building on the demonstrated manufacturing performance of monoclonal antibodies (mAbs) for rapid response, the U.S. government aims to strengthen domestic preparedness against threats such as anthrax, Ebola, RSV, and SARS-CoV-2 by advancing technologies that improve the speed, efficiency, and resilience of mAb production. Feedback will be shared with the U.S. government to support planning and development efforts.

Responses Due: Sept. 1, 2025 at 11:59 p.m. ET

Learn More

AI Webinar

AI Advances & FDA Insights in
Pharmaceutical Manufacturing Webinar

Gain insights from three leaders driving innovation at the intersection of AI and pharmaceutical manufacturing. This webinar will cover cutting-edge technologies and innovations, real-world applications of AI in pharmaceutical manufacturing, key FDA insights, and partnership and collaboration opportunities.

When: Sept. 10, 2025 from 1 to 2 p.m. ET

Get involved!

Seeking partnerships to rapidly respond to future Public Health Emergencies (PHE)

Member Benefits:

No Cost Barrier for Entry

Pre-negotiated Terms

Fast & Flexible Partnerships

Networking & Engagement with Industry

JOIN NOW

Industrial Base Expansion of Supply Chain

Engage with the network of organizations and personnel that provide all goods and services in support of the entire biomanufacturing process, to include, but not limited to, raw materials, consumables, and fill-finish services.

Biomanufacturing Capacity Expansion and Reservation

Prepare and provide timely, integrated, and sufficient medical countermeasures in response to emerging pathogens with pandemic potential through establishing, expanding and/or reserving drug substance and/or drug product manufacturing capacities.

Advanced Biomanufacturing Technologies

Address new and emerging technologies, that enhance existing capabilities that increase the speed, quality, safety, yield, efficiency of the biomanufacturing process or the safety, quality, effectiveness, or availability of the resulting biopharmaceutical drug product.